AU5938996A - Method for encapsulating pharmaceutical materials - Google Patents

Method for encapsulating pharmaceutical materials

Info

Publication number
AU5938996A
AU5938996A AU59389/96A AU5938996A AU5938996A AU 5938996 A AU5938996 A AU 5938996A AU 59389/96 A AU59389/96 A AU 59389/96A AU 5938996 A AU5938996 A AU 5938996A AU 5938996 A AU5938996 A AU 5938996A
Authority
AU
Australia
Prior art keywords
pharmaceutical materials
encapsulating pharmaceutical
encapsulating
materials
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59389/96A
Inventor
Eric A Forssen
Mitsuo Oka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nexstar Pharmaceuticals Inc
Original Assignee
Nexstar Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nexstar Pharmaceuticals Inc filed Critical Nexstar Pharmaceuticals Inc
Publication of AU5938996A publication Critical patent/AU5938996A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
AU59389/96A 1995-06-07 1996-05-29 Method for encapsulating pharmaceutical materials Abandoned AU5938996A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US483606 1990-02-22
US48360695A 1995-06-07 1995-06-07
PCT/US1996/007892 WO1996040061A1 (en) 1995-06-07 1996-05-29 Method for encapsulating pharmaceutical materials

Publications (1)

Publication Number Publication Date
AU5938996A true AU5938996A (en) 1996-12-30

Family

ID=23920761

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59389/96A Abandoned AU5938996A (en) 1995-06-07 1996-05-29 Method for encapsulating pharmaceutical materials

Country Status (2)

Country Link
AU (1) AU5938996A (en)
WO (1) WO1996040061A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4430592A1 (en) 1994-08-20 1996-02-22 Max Delbrueck Centrum Liposomal preparation, its preparation and its use
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
CA2628570A1 (en) 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
EP3246034A1 (en) 2008-03-06 2017-11-22 Anacor Pharmaceuticals, Inc. Boron-containing small molecules as anti-inflammatory agents
EP3485881B1 (en) 2009-07-10 2024-03-13 President and Fellows of Harvard College Permanently charged sodium and calcium channel blockers as anti-inflammatory agents
JP6200648B2 (en) 2009-12-18 2017-09-20 アケリオス セラピューティクス，インコーポレーテッド Composition for the treatment and prevention of trigeminal and autonomic headache, migraine and vascular symptoms
WO2011094450A1 (en) 2010-01-27 2011-08-04 Anacor Pharmaceuticals, Inc Boron-containing small molecules
EP3226972A4 (en) 2014-12-01 2018-08-08 Achelios Therapeutics, Inc. Methods and compositions for treating migraine and conditions associated with pain
MX2018001447A (en) 2015-08-03 2019-02-21 Harvard College Charged ion channel blockers and methods for use.
EP3500581A4 (en) 2016-08-17 2021-10-06 Solstice Biologics, Ltd. Polynucleotide constructs
FI3600435T3 (en) 2017-03-23 2024-04-10 Lipid Systems Sp Z O O High-efficiency encapsulation of hydrophilic compounds in unilamellar liposomes
US11597744B2 (en) 2017-06-30 2023-03-07 Sirius Therapeutics, Inc. Chiral phosphoramidite auxiliaries and methods of their use
WO2020185881A1 (en) 2019-03-11 2020-09-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10786485B1 (en) 2019-03-11 2020-09-29 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US10780083B1 (en) 2019-03-11 2020-09-22 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
JP2022527438A (en) 2019-03-11 2022-06-02 ノシオン セラピューティクス，インコーポレイテッド Charged ion channel blockers and usage
US10927096B2 (en) 2019-03-11 2021-02-23 Nocion Therapeutics, Inc. Ester substituted ion channel blockers and methods for use
JP2023500891A (en) 2019-11-06 2023-01-11 ノシオン セラピューティクス，インコーポレイテッド Charged ion channel blockers and methods of use
WO2021091586A1 (en) 2019-11-06 2021-05-14 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US11332446B2 (en) 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3161962D1 (en) * 1980-07-01 1984-02-23 Oreal Process for obtaining stable dispersions in an aqueous phase of at least a water immiscible liquid phase, and corresponding dispersions
GR77320B (en) * 1980-12-22 1984-09-11 Procter & Gamble
DE4221256C2 (en) * 1992-06-26 1997-07-10 Lancaster Group Ag Galenic composition for topical use

Also Published As

Publication number Publication date
WO1996040061A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
AU5938996A (en) Method for encapsulating pharmaceutical materials
AU4053697A (en) Method for packaging microsensors
AU6995396A (en) Pharmaceutical formulation
AU6910096A (en) Method and apparatus for encapsulating particulates
AU6973396A (en) Pharmaceutical formulation
AU7590096A (en) Drug composition
AU6645898A (en) Method for destroying energetic materials
AU6904896A (en) Pharmaceutical compounds
AU5277696A (en) Packaging material
AU4838996A (en) Process for tetraazacycloalkane preparation
AU5155096A (en) Pharmaceutical composition
AU4619596A (en) Method for determining the particle size of a material
IL117397A0 (en) Novel naphthyl pharmaceutical compounds
AU7582696A (en) Pharmaceutical formulation
AU5280396A (en) Pharmaceutical microencapsulation
AU2163299A (en) Method for inhaling powdery substances
AU7546096A (en) Pharmaceutical compounds
AU1687197A (en) Encapsulating material for photovoltaic devices
AU4233997A (en) Process for preparing pharmaceutical compounds
AU6670796A (en) Method for manufacturing fishtraps
AU5098096A (en) Materials handling system
AU1101797A (en) Method for making fluoroalkanols
AU4474496A (en) Packaging material
AU5271296A (en) Novel method
AU1101197A (en) Method for destroying termitaria